Stay updated on Carboplatin-Paclitaxel/Pembrolizumab in Lung Cancer Clinical Trial

Sign up to get notified when there's something new on the Carboplatin-Paclitaxel/Pembrolizumab in Lung Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Carboplatin-Paclitaxel/Pembrolizumab in Lung Cancer Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    The page footer now shows 'Revision: v3.5.4' replacing 'v3.5.3'. This indicates a minor platform update to the page rendering rather than a change to study data.
    Difference
    0.1%
    Check dated 2026-05-15T05:29:01.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    The page footer updated to show Revision: v3.5.3, indicating a new page version. The core study record content remains unchanged.
    Difference
    0.1%
    Check dated 2026-04-30T18:42:17.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    The page footer now shows Revision: v3.5.2, replacing Revision: v3.5.0.
    Difference
    0.1%
    Check dated 2026-04-16T11:15:00.000Z thumbnail image
  6. Check
    67 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.3 to v3.5.0 on the page.
    Difference
    0.1%
    Check dated 2026-03-18T19:28:38.000Z thumbnail image
  7. Check
    75 days ago
    Change Detected
    Summary
    Added revision v3.4.3 and removed revision v3.4.2 from the record history.
    Difference
    0.1%
    Check dated 2026-03-11T17:16:12.000Z thumbnail image
  8. Check
    103 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2 and removed notices about government funding lapse and Revision: v3.4.1.
    Difference
    0.4%
    Check dated 2026-02-11T02:07:47.000Z thumbnail image

Stay in the know with updates to Carboplatin-Paclitaxel/Pembrolizumab in Lung Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Carboplatin-Paclitaxel/Pembrolizumab in Lung Cancer Clinical Trial page.